» Articles » PMID: 15728477

Differential Effects of IL-21 During Initiation and Progression of Autoimmunity Against Neuroantigen

Overview
Journal J Immunol
Date 2005 Feb 25
PMID 15728477
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The cytokine IL-21 is closely related to IL-2 and IL-15, a cytokine family that uses the common gamma-chain for signaling. IL-21 is expressed by activated CD4(+) T cells. We examined the role of IL-21 in the autoimmune disease experimental autoimmune encephalomyelitis (EAE), an animal model for human multiple sclerosis. IL-21 administration before induction of EAE with a neuroantigen, myelin oligodendrocyte glycoprotein peptide 35-55, and adjuvant enhanced the inflammatory influx into the CNS, as well as the severity of EAE. Autoreactive T cells purified from IL-21-treated mice transferred more severe EAE than did the control encephalitogenic T cells. No such effects were observed when IL-21 was administered after EAE progressed. Additional studies demonstrated that IL-21 given before the induction of EAE boosted NK cell function, including secretion of IFN-gamma. Depletion of NK cells abrogated the effect of IL-21. Therefore, IL-21, by affecting NK cells, has differential effects during the initiation and progression of autoimmune responses against neuroantigens.

Citing Articles

Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis.

Dubik M, Marczynska-Grzelak J, Sorensen M, Dieu R, Rusin D, Schioth E Int J Mol Sci. 2024; 25(13).

PMID: 39000569 PMC: 11242768. DOI: 10.3390/ijms25137462.


The Role of Selected Interleukins in the Development and Progression of Multiple Sclerosis-A Systematic Review.

Grunwald C, Kretowska-Grunwald A, Adamska-Patruno E, Kochanowicz J, Kulakowska A, Chorazy M Int J Mol Sci. 2024; 25(5).

PMID: 38473835 PMC: 10932438. DOI: 10.3390/ijms25052589.


Exaggerated levels of some specific TLRs, cytokines and chemokines in Japanese encephalitis infected BV2 and neuro 2A cell lines associated with worst outcome.

Shukla M, Garg A, Dhole T, Chaturvedi R Virol J. 2023; 20(1):16.

PMID: 36707891 PMC: 9881527. DOI: 10.1186/s12985-023-01966-8.


Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis.

Edo A, Calvo-Barreiro L, Eixarch H, Bosch A, Chillon M, Espejo C Neurotherapeutics. 2022; 19(5):1617-1633.

PMID: 35902536 PMC: 9606180. DOI: 10.1007/s13311-022-01279-8.


Impact of IL-21 Gene Polymorphisms (rs2055979) and the Levels of Serum IL-21 on the Risk of Multiple Sclerosis.

Ali Abdulla A, Abdulaali Abed T, Razzaq Abdul-Ameer W Arch Razi Inst. 2022; 77(1):81-86.

PMID: 35891764 PMC: 9288640. DOI: 10.22092/ARI.2021.356470.1848.